🇺🇸 FDA
Pipeline program

PEG-interferon-Alfa-2A

ML25659

Phase 3 small_molecule active

Quick answer

PEG-interferon-Alfa-2A for Chronic Hepatitis B is a Phase 3 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Chronic Hepatitis B
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials